InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Haley Pamela. Director active across 2 companies, notably Arcadia Biosciences, Inc.. Aggregated, 2 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €478. Activity tracked since 1 August 2022. The latest transaction was filed on 1 September 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations